ArticleScientific reports2025
Antimicrobial, antibiofilm and antioxidant activities of bioactive secondary metabolites of marine Scarus ghobban gut-associated Aspergillus niger: In-vitro and in-silico studies.
Article in Scientific reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Exploring Marinilactibacillus sp from Lake Urmia as a novel halophilic source of antibacterial bioactive compounds.Extremophiles : life under extreme conditions · 2026Article
- Isolation, characterization, and biological evaluation of endophytic fungi fromFrontiers in molecular biosciences · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Fungal extracts have garnered significant interest in recent years for their diverse applications in pharmaceutical field. This research focused on isolating fungi from the gut of Scarus ghobban for the first time and evaluate their biological activities Aspergillus niger was successfully isolated and identified using morphological and molecular techniques. Gas chromatography-mass spectrometry (GC-MS) analysis of the ethyl acetate extract (EA) of A. niger revealed eight compounds, with diisooctyl phthalate (54.32%) and 1,2-benzenedicarboxylic acid, bis (2-methoxyethyl) ester (26.32%) as the most abundant. High-performance liquid chromatography (HPLC) analysis identified catechol (15.41 µg/mL) and syringenic acid (13.25 µg/mL) as prominent phenolic compounds in the extract. The EA extract exhibited significant antibacterial activity toward pathogenic bacterial strains, with the highest inhibition zone (32 ± 0.1 mm) and minimum inhibitory concentration (MIC) of 7.8 µg/mL against Bacillus subtilis. Additionally, it showed antifungal activity against Candida tropicalis (MIC 7.8 µg/mL) and Candida albicans (MIC 31.25 µg/mL). The extract also demonstrated potential antibiofilm activity against Salmonella typhimurium, Staphylococcus aureus, Enterococcus faecalis, and Escherichia coli, with inhibition percentages exceeding 87%. Moreover, it exhibited potent antioxidant activity IC50 8.17 µg/mL. Transmission electron microscopy revealed severe structural damage in B. subtilis, emphasizing the extract's antibacterial effectiveness and potential for therapeutic applications. Eventually, docking studies and computational calculations have been utilized to demonstrate the reactivity of the molecules. In conclusion, the ethyl acetate extract of A. niger from gut of S. ghobban demonstrates significant antibacterial, antibiofilm, and antioxidant activities, highlighting its potential as a valuable resource for developing effective antimicrobial agents and therapeutic applications.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.